“吉林红丹三号”系一种新型祖国丹药复方制剂,主治脑血栓形成所致的偏瘫,临床试用有较好的疗效。本文为其毒理学及药效学提供依据。实验证明“三号”的急性毒性不明显;亚急性毒性表明相当于临床连续服用30天的量是安全的。根据“三号”的抗血栓形成作用及其对血栓弹力图的影响,其药效似乎与血液学的变化,特别是血小板及凝血功能有关。 “Jilin Hongdan No.3” is a new type of compound preparation of the motherland and the Chinese medicine, which is used to treat hemiplegia caused by cerebral thrombosis. Clinical trials have a good effect. This article provides the basis for its toxicology and pharmacodynamics. Experiments have shown that the acute toxicity of “No. 3” is not obvious; subacute toxicity indicates that it is safe to administer an amount equivalent to 30 days of continuous clinical use. Based on the anti-thrombotic effect of “No. 3” and its effect on the thrombo-elasticity map, its efficacy seems to be related to changes in hematology, especially platelet and coagulation function.